As you know, Strep. uberis is now the most common infectious agent isolated from milk samples
submitted to the VLA regional labs.1 Strep. uberis leads to high somatic cell counts (SCC)
and clinical mastitis that is difficult to cure.2
And both are associated with substantial economic loss.Best practice -
which improves clinical outcomes - requires a diagnostic test.
Identifying the pathogen allows targeted antimicrobial therapy and
improves control of the pathogen in the herd.
In acute clinical cases, where immediate treatment
is necessary, sampling is still valuable because improved
understanding of the infectious agents
in the herd helps make future management more
specific and therefore more efficient.
Once Strep. uberis has been confirmed, treatment with
Mamyzin continues best practice.
Strep. uberis is particularly vulnerable to Mamyzin.
Partly because Mamyzin concentrates preferentially,
where it's needed, in the udder.3
Resistance in the UK is rare,2 consequently cure rates
are very high and SCCs decline rapidly.
This, and the fact that all quarters are treated
at once, makes Mamyzin the kind of smart weapon many of
you have been seeking, for use against Strep uberis.
Together we can do what's best for herds.
This, after all, is in everyone's best interests.
For printable information the monograph can be downloaded here in adobe acrobat format